Detalhe da pesquisa
1.
Validation of National Early Warning Score and Quick Sequential (sepsis-related) Organ Failure Assessment in acute myeloid leukaemia patients treated with intensive chemotherapy.
Eur J Haematol
; 110(6): 696-705, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36919878
2.
Effects of erythropoiesis-stimulating agents on overall survival of International Prognostic Scoring System Low/Intermediate-1 risk, transfusion-independent myelodysplastic syndrome patients: a cohort study.
Haematologica
; 104(1): e4-e8, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30076178
3.
Deferasirox is a powerful NF-kappaB inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavenging.
Haematologica
; 95(8): 1308-16, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20534700
4.
Emerging drugs for chronic myeloid leukemia.
Expert Opin Emerg Drugs
; 15(2): 175-84, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20201747
5.
Effects of different doses of erythropoietin in patients with myelodysplastic syndromes: A propensity score-matched analysis.
Cancer Med
; 8(18): 7567-7576, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31657156
6.
Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapy.
Haematologica
; 93(6): 921-4, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18443273
7.
Imatinib mesylate in the treatment of newly diagnosed or refractory/resistant c-KIT positive acute myeloid leukemia. Results of an Italian Multicentric Phase II Study.
Haematologica
; 92(12): 1721-2, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18056005
8.
Genetic abnormalities as targets for molecular therapies in myelodysplastic syndromes.
Ann N Y Acad Sci
; 1089: 411-23, 2006 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17261784
9.
SARS-CoV-2 in Myelodysplastic Syndromes: A Snapshot From Early Italian Experience.
Hemasphere
; 4(5): e483, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33062948
10.
Myelodysplastic syndromes.
Ann N Y Acad Sci
; 1028: 400-8, 2004 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15650265
11.
Rational approaches to the design of therapeutics targeting molecular markers: the case of chronic myelogenous leukemia.
Ann N Y Acad Sci
; 1028: 423-31, 2004 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15650267
12.
Detection of humoral immune responses against WT1 antigen in patients affected by different hematological malignancies.
Acta Haematol
; 120(1): 47-50, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18824841
13.
Core binding factor acute myeloid leukaemia and c-KIT mutations.
Oncol Rep
; 29(5): 1867-72, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23467883
14.
Arsenic trioxide and ascorbic acid interfere with the BCL2 family genes in patients with myelodysplastic syndromes: an ex-vivo study.
J Hematol Oncol
; 5: 53, 2012 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-22964015
15.
Erythroid response during iron chelation therapy in a cohort of patients affected by hematologic malignancies and aplastic anemia with transfusion requirement and iron overload: a FISM Italian multicenter retrospective study.
Leuk Lymphoma
; 58(11): 2752-2754, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28482720
16.
Iron chelation therapy in myelodysplastic syndromes.
Adv Hematol
; 2010: 756289, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20672005
17.
Increase in platelet count in older, poor-risk patients with acute myeloid leukemia or myelodysplastic syndrome treated with valproic acid and all-trans retinoic acid.
Cancer
; 104(1): 101-9, 2005 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15895376
18.
Sensitivity to imatinib therapy may be predicted by testing Wilms tumor gene expression and colony growth after a short in vitro incubation.
Cancer
; 101(5): 979-88, 2004 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15329907
19.
Imatinib and pegylated human recombinant interferon-alpha2b in early chronic-phase chronic myeloid leukemia.
Blood
; 104(13): 4245-51, 2004 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15319292
20.
Down-modulation of the C/EBPalpha transcription factor in core binding factor acute myeloid leukemias.
Blood
; 102(7): 2705-6, 2003 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14504076